CompletedNot Applicable

Mortality Related to AMR in Patients With Hospital-acquired Infection

Thailand2,069 participantsStarted 2018-03-01

Plain-language summary

This is a prospective surveillance study to estimate excess deaths due to and risk factors associated with antibiotic-resistant infection among patients with hospital-acquired infection (HAI) in a resource-limited setting. We will focus on six pathogenic bacteria that are of clinically important in the hospital.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female of any age admit at Sunpasitthiprasong Hospital * At least one of the six organisms, which include Staphylococcus aureus, Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp., isolated from clinical specimen \>48 hours after admission * Acquired Bloodstream infection (BSI), Lower-respiratory tract infection(LRTI), Skin/Soft tissue infection (SSTI), Surgical-site infection (SSI), Urinary tract infection (UTI) or infection at other body sites \>48 hours after admit at the hospital Exclusion Criteria: • Clinical symptoms of current infection presented ≤48 hours of admission

What they're measuring

28-day mortality

Timeframe: 28 days

Trial details

NCT IDNCT03411538

SponsorUniversity of Oxford

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-02-28

View on ClinicalTrials.gov More Hospital-acquired Infections trials